Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia, Lymphocytic, Chronic, B-Cell 19Myelodysplastic Syndromes 17Hodgkin Disease 17Lymphoma, Non-Hodgkin 15Myeloproliferative Disorders 13Multiple Myeloma 13Lymphoma, Mantle-Cell 13Leukemia, Myelomonocytic, Chronic 13Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myeloid, Chronic-Phase 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Prolymphocytic 10Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Biphenotypic, Acute 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Primary Myelofibrosis 6Myelodysplastic-Myeloproliferative Diseases 6Lymphoma 5Graft vs Host Disease 5Congenital Abnormalities 5Blast Crisis 5Recurrence 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Prolymphocytic, T-Cell 4

Interventions

Cyclophosphamide 53Etoposide 33Temozolomide 28Irinotecan 28Melphalan 25Filgrastim 25Topotecan 24Carboplatin 243-Iodobenzylguanidine 23Isotretinoin 20Granulocyte Colony-Stimulating Factor 17sargramostim 16humanized 3F8 anti-GD2 monoclonal antibody 16dinutuximab 16Granulocyte-Macrophage Colony-Stimulating Factor 16fludarabine 15Vincristine 15Doxorubicin 15Cisplatin 15Peripheral Blood Stem Cell Transplantation 14Interleukin-2 14Busulfan 13naxitamab 12Thiotepa 12Radiotherapy 12aldesleukin 11fludarabine phosphate 10etoposide phosphate 8Mesna 8Ifosfamide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neuroblastoma × Cyclosporins × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡